EV/EBITDA Ratio: 29.94x
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 29.94x is in line with its 5-year average of 29.04x, around the middle of its 5-year range (17.07x–48.16x).
As of Saturday, June 27, 2026. 25.66% above its 12-month average of 23.83x.
WST EV/EBITDA Ratio Chart
WST Average EV/EBITDA Ratio Chart
WST Current vs Average EV/EBITDA Ratio Chart
WST EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
29.94x
EV/EBITDA RATIO AVG TTM
23.83x
EV/EBITDA RATIO AVG 3Y
27.65x
EV/EBITDA RATIO AVG 5Y
28.96x
EV/EBITDA RATIO AVG 10Y
28.71x
EV/EBITDA RATIO AVG 15Y
23.93x
EV/EBITDA RATIO AVG 20Y
20.62x
CURRENT VS TTM AVG
+25.66%
CURRENT VS 3Y AVG
+8.29%
CURRENT VS 5Y AVG
+3.37%
CURRENT VS 10Y AVG
+4.29%
CURRENT VS 15Y AVG
+25.12%
CURRENT VS 20Y AVG
+45.18%
WST Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.79B | 29.94x | 23.83x | 27.65x | 28.96x |
| Waters Corporation (WAT)vs › | $24.41B | 37.64x | 22.33x | 21.78x | 21.91x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.54B | 21.83x | 23.41x | 23.62x | 26.24x |
| Quest Diagnostics Incorporated (DGX)vs › | $23.23B | 14.46x | 13.22x | 12.93x | 11.16x |
| BioNTech SE (BNTX)vs › | $23.07B | N/A | 4.16x | 5.53x | 5.53x |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 16.09x | 13.31x | 11.35x | 12.46x |
| Moderna, Inc. (MRNA)vs › | $26.69B | N/A | 15.48x | 26.88x | 26.88x |
| Incyte Corporation (INCY)vs › | $22.73B | 13.01x | 15.43x | 63.58x | 47.20x |
| DexCom, Inc. (DXCM)vs › | $27.07B | 21.57x | 28.52x | 47.87x | 73.65x |
| Labcorp Holdings Inc. (LH)vs › | $22.26B | 12.80x | 14.31x | 15.99x | 12.61x |
EV/EBITDA vs. its own history
At 29.9, EV/EBITDA is richer than usual, sitting higher than 83% of its 20-year history.
20-year low
7.1
median
20.5
20-year high
50.6
EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The EV/EBITDA ratio for WST stock is 29.94x.
- Is West Pharmaceutical Services, Inc.'s EV/EBITDA ratio high or low?
- The EV/EBITDA ratio of 29.94x is in line with its 5-year average of 29.04x, around the middle of its 5-year range (17.07x–48.16x).
- What is the TTM average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The TTM average EV/EBITDA ratio for WST stock is 23.83x.
- What is the 3Y average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The 3Y average EV/EBITDA ratio for WST stock is 27.65x.
- What is the 5Y average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The 5Y average EV/EBITDA ratio for WST stock is 28.96x.
- What is the 10Y average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The 10Y average EV/EBITDA ratio for WST stock is 28.71x.
- What is the 15Y average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The 15Y average EV/EBITDA ratio for WST stock is 23.93x.
- What is the 20Y average EV/EBITDA ratio for West Pharmaceutical Services, Inc. (WST)?
- The 20Y average EV/EBITDA ratio for WST stock is 20.62x.
WST EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-26 | 29.94x |
| 2026-06-25 | 29.57x |
| 2026-06-24 | 29.04x |
| 2026-06-23 | 28.69x |
| 2026-06-22 | 28.12x |
| 2026-06-18 | 27.97x |
| 2026-06-17 | 27.59x |
| 2026-06-16 | 28.11x |
| 2026-06-15 | 28.27x |
| 2026-06-12 | 28.04x |
| 2026-06-11 | 28.17x |
| 2026-06-10 | 28.22x |
| 2026-06-09 | 28.55x |
| 2026-06-08 | 27.26x |
| 2026-06-05 | 26.81x |
| 2026-06-04 | 27.05x |
| 2026-06-03 | 26.97x |
| 2026-06-02 | 26.61x |
| 2026-06-01 | 26.97x |
| 2026-05-29 | 27.53x |
| 2026-05-28 | 27.44x |
| 2026-05-27 | 26.66x |
| 2026-05-26 | 26.96x |
| 2026-05-22 | 26.98x |
| 2026-05-21 | 26.95x |
| 2026-05-20 | 26.04x |
| 2026-05-19 | 25.90x |
| 2026-05-18 | 25.94x |
| 2026-05-15 | 25.81x |
| 2026-05-14 | 25.58x |
| 2026-05-13 | 25.77x |
| 2026-05-12 | 26.60x |
| 2026-05-11 | 27.48x |
| 2026-05-08 | 27.79x |
| 2026-05-07 | 27.46x |
| 2026-05-06 | 26.64x |
| 2026-05-05 | 26.42x |
| 2026-05-04 | 25.58x |
| 2026-05-01 | 25.62x |
| 2026-04-30 | 25.36x |
| 2026-04-29 | 25.17x |
| 2026-04-28 | 24.89x |
| 2026-04-27 | 25.75x |
| 2026-04-24 | 26.09x |
| 2026-04-23 | 26.40x |
| 2026-04-22 | 24.71x |
| 2026-04-21 | 24.74x |
| 2026-04-20 | 25.04x |
| 2026-04-17 | 24.65x |
| 2026-04-16 | 24.29x |
| 2026-04-15 | 23.98x |
| 2026-04-14 | 24.11x |
| 2026-04-13 | 23.38x |
| 2026-04-10 | 23.06x |
| 2026-04-09 | 23.25x |
| 2026-04-08 | 23.93x |
| 2026-04-07 | 23.32x |
| 2026-04-06 | 23.09x |
| 2026-04-02 | 22.90x |
| 2026-04-01 | 22.71x |
| 2026-03-31 | 22.52x |
| 2026-03-30 | 22.01x |
| 2026-03-27 | 21.85x |
| 2026-03-26 | 22.29x |
| 2026-03-25 | 22.18x |
| 2026-03-24 | 22.02x |
| 2026-03-23 | 21.67x |
| 2026-03-20 | 21.26x |
| 2026-03-19 | 21.57x |
| 2026-03-18 | 21.45x |
| 2026-03-17 | 21.48x |
| 2026-03-16 | 21.57x |
| 2026-03-13 | 21.12x |
| 2026-03-12 | 20.72x |
| 2026-03-11 | 21.38x |
| 2026-03-10 | 20.97x |
| 2026-03-09 | 22.28x |
| 2026-03-06 | 22.08x |
| 2026-03-05 | 21.94x |
| 2026-03-04 | 22.35x |
| 2026-03-03 | 22.59x |
| 2026-03-02 | 22.57x |
| 2026-02-27 | 22.86x |
| 2026-02-26 | 22.37x |
| 2026-02-25 | 22.26x |
| 2026-02-24 | 22.03x |
| 2026-02-23 | 21.93x |
| 2026-02-20 | 21.64x |
| 2026-02-19 | 21.89x |
| 2026-02-18 | 22.30x |
| 2026-02-17 | 21.83x |
| 2026-02-13 | 22.46x |
| 2026-02-12 | 21.83x |
| 2026-02-11 | 22.07x |
| 2026-02-10 | 21.83x |
| 2026-02-09 | 22.32x |
| 2026-02-06 | 22.32x |
| 2026-02-05 | 20.74x |
| 2026-02-04 | 21.23x |
| 2026-02-03 | 20.68x |
| 2026-02-02 | 21.28x |
| 2026-01-30 | 20.69x |
| 2026-01-29 | 20.83x |
| 2026-01-28 | 21.13x |
| 2026-01-27 | 21.55x |
| 2026-01-26 | 21.63x |
| 2026-01-23 | 21.20x |
| 2026-01-22 | 22.21x |
| 2026-01-21 | 22.89x |
| 2026-01-20 | 22.46x |
| 2026-01-16 | 23.31x |
| 2026-01-15 | 25.10x |
| 2026-01-14 | 24.70x |
| 2026-01-13 | 24.41x |
| 2026-01-12 | 24.51x |
| 2026-01-09 | 24.75x |
| 2026-01-08 | 24.72x |
| 2026-01-07 | 25.01x |
| 2026-01-06 | 25.22x |
| 2026-01-05 | 25.07x |
| 2026-01-02 | 24.83x |
| 2025-12-31 | 24.71x |
| 2025-12-30 | 24.87x |
| 2025-12-29 | 24.76x |
| 2025-12-26 | 24.64x |
| 2025-12-24 | 24.85x |
| 2025-12-23 | 24.93x |
| 2025-12-22 | 24.69x |
| 2025-12-19 | 24.48x |
| 2025-12-18 | 24.12x |
| 2025-12-17 | 24.16x |
| 2025-12-16 | 23.92x |
| 2025-12-15 | 24.41x |
| 2025-12-12 | 24.02x |
| 2025-12-11 | 24.48x |
| 2025-12-10 | 23.97x |
| 2025-12-09 | 23.88x |
| 2025-12-08 | 24.16x |
| 2025-12-05 | 25.18x |
| 2025-12-04 | 25.32x |
| 2025-12-03 | 25.55x |
| 2025-12-02 | 24.52x |
| 2025-12-01 | 24.62x |
| 2025-11-28 | 24.91x |
| 2025-11-26 | 24.90x |
| 2025-11-25 | 25.23x |
| 2025-11-24 | 24.61x |
| 2025-11-21 | 24.34x |
| 2025-11-20 | 23.13x |
| 2025-11-19 | 23.14x |
| 2025-11-18 | 23.34x |
| 2025-11-17 | 23.55x |
| 2025-11-14 | 23.45x |
| 2025-11-13 | 23.94x |
| 2025-11-12 | 24.60x |
| 2025-11-11 | 24.92x |
| 2025-11-10 | 24.74x |
| 2025-11-07 | 24.34x |
| 2025-11-06 | 24.73x |
| 2025-11-05 | 25.48x |
| 2025-11-04 | 25.79x |
| 2025-11-03 | 25.14x |
| 2025-10-31 | 25.35x |
| 2025-10-30 | 25.02x |
| 2025-10-29 | 25.60x |
| 2025-10-28 | 25.48x |
| 2025-10-27 | 25.82x |
| 2025-10-24 | 26.75x |
| 2025-10-23 | 27.65x |
| 2025-10-22 | 25.35x |
| 2025-10-21 | 25.57x |
| 2025-10-20 | 25.16x |
| 2025-10-17 | 24.76x |
| 2025-10-16 | 24.44x |
| 2025-10-15 | 24.05x |
| 2025-10-14 | 23.89x |
| 2025-10-13 | 24.01x |
| 2025-10-10 | 23.94x |
| 2025-10-09 | 24.11x |
| 2025-10-08 | 24.51x |
| 2025-10-07 | 24.33x |
| 2025-10-06 | 24.53x |
| 2025-10-03 | 24.94x |
| 2025-10-02 | 25.00x |
| 2025-10-01 | 24.84x |
| 2025-09-30 | 23.99x |
| 2025-09-29 | 23.81x |
| 2025-09-26 | 23.92x |
| 2025-09-25 | 23.27x |
| 2025-09-24 | 23.77x |
| 2025-09-23 | 22.93x |
| 2025-09-22 | 23.06x |
| 2025-09-19 | 23.30x |
| 2025-09-18 | 23.32x |
| 2025-09-17 | 23.47x |
| 2025-09-16 | 23.63x |
| 2025-09-15 | 23.55x |
| 2025-09-12 | 23.18x |
| 2025-09-11 | 24.13x |
| 2025-09-10 | 23.34x |
| 2025-09-09 | 23.04x |
| 2025-09-08 | 23.15x |
| 2025-09-05 | 22.92x |
| 2025-09-04 | 22.63x |
| 2025-09-03 | 22.76x |
| 2025-09-02 | 22.28x |
| 2025-08-29 | 22.57x |
| 2025-08-28 | 22.43x |
| 2025-08-27 | 22.48x |
| 2025-08-26 | 22.35x |
| 2025-08-25 | 22.60x |
| 2025-08-22 | 22.66x |
| 2025-08-21 | 22.17x |
| 2025-08-20 | 22.52x |
| 2025-08-19 | 22.58x |
| 2025-08-18 | 22.22x |
| 2025-08-15 | 22.50x |
| 2025-08-14 | 22.50x |
| 2025-08-13 | 22.51x |
| 2025-08-12 | 21.92x |
| 2025-08-11 | 21.96x |
| 2025-08-08 | 22.02x |
| 2025-08-07 | 21.98x |
| 2025-08-06 | 21.68x |
| 2025-08-05 | 21.82x |
| 2025-08-04 | 21.78x |
| 2025-08-01 | 21.86x |
| 2025-07-31 | 21.86x |
| 2025-07-30 | 22.78x |
| 2025-07-29 | 23.13x |
| 2025-07-28 | 23.57x |
| 2025-07-25 | 24.10x |
| 2025-07-24 | 25.55x |
| 2025-07-23 | 21.78x |
| 2025-07-22 | 20.96x |
| 2025-07-21 | 20.11x |
| 2025-07-18 | 20.19x |
| 2025-07-17 | 21.22x |
| 2025-07-16 | 21.49x |
| 2025-07-15 | 21.17x |
| 2025-07-14 | 21.50x |
| 2025-07-11 | 21.76x |
| 2025-07-10 | 21.96x |
| 2025-07-09 | 21.67x |
| 2025-07-08 | 21.12x |
| 2025-07-07 | 21.21x |
| 2025-07-03 | 21.29x |
| 2025-07-02 | 21.19x |
| 2025-07-01 | 21.30x |
| 2025-06-30 | 20.96x |
| 2025-06-27 | 20.96x |
| 2025-06-26 | 20.97x |
| 2025-06-25 | 21.17x |
| 2025-06-24 | 21.33x |
| 2025-06-23 | 20.75x |
| 2025-06-20 | 20.67x |
| 2025-06-18 | 20.87x |
| 2025-06-17 | 20.88x |
| 2025-06-16 | 21.49x |
| 2025-06-13 | 21.25x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green